Provincial Health Officer II Dr. Edward Tandingan presented during the regular Provincial Interagency Task Force meeting today that as of April 26, 2021, the province recorded a total of 3,878 total cases with 3,249 recoveries or 83.8 percent and death of 45 or 1.2%.
With a 2-week Growth Rate of 12.2(medium), high Average Daily Attack Rate of 19.9, and infection fatality rate of 11.8 per thousand, the epidemic risk level of the province is high with an equivalent quarantine response of Modified Enhanced Community Quarantine.
The latest data showed that the municipality of Tanudan remains at critical risk; Lubuagan, Pinukpuk, and the City of Tabuk are high risk while Balbalan, Pasil, and Rizal are categorized as medium epidemic risk.
Based on the distribution of confirmed cases from April 1 to 26, 2021, Tabuk City recorded the highest with 699 of the cumulative new cases. From the weekly cumulative new cases per LGU for April 2021, Tabuk City also exhibited the steepest slope while the municipality of Tinglayan showed the flattest.
“Almost twice the number of new confirmed cases was recorded for April as compared to the month of March. From the distribution of confirmed cases from April 1 to 26, 2021, Tabuk City displayed the highest number with 699 or 64% of the cumulative new cases”, Tandingan explained.
During the same period, the average daily number of recoveries is 31 compared to the 42 daily average cases.
On the Temporary Treatment and Monitoring Facility Bed Occupancy Rate, Kalinga is under moderate risk category which was attributed to the addition of 16 beds at the Kalinga Provincial Hospital TTMF.
Tandingan said the province remains above the average bed occupancy rate trend for the Cordillera Administrative Region.
For vaccine utilization, the PHO reported that 87.8% or 4,747 of the total 5,410 doses of vaccines allocated for the province were already utilized.
The third tranche of vaccines composed of 2,750 doses from the Center for Health Development - CAR arrived last April 27 for the second dose of those ( Priority Groups A1, A2, A3) inoculated with CoronaVac Sinovac vaccine. (JDP/PAB-PIA CAR, Kalinga with reports from PLGU-PIO)
By Peter A. Balocnit